Cargando…
Antitumor effects of ribavirin in combination with TMZ and IFN-β in malignant glioma cells
The prognosis of gioblastoma, the standard chemotherapy agent for which is temozolomide (TMZ), remains poor despite recent advances in multimodal treatments. Therefore, it is necessary to identify and develop novel therapeutics for this malignant disease. Ribavirin, an anti-viral agent which is one...
Autores principales: | Ochiai, Yushi, Sumi, Koichiro, Sano, Emiko, Yoshimura, Sodai, Yamamuro, Shun, Ogino, Akiyoshi, Ueda, Takuya, Suzuki, Yutaka, Nakayama, Tomohiro, Hara, Hiroyuki, Katayama, Yoichi, Yoshino, Atsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475644/ https://www.ncbi.nlm.nih.gov/pubmed/32934745 http://dx.doi.org/10.3892/ol.2020.12039 |
Ejemplares similares
-
Efficacy of ribavirin against malignant glioma cell lines: Follow-up study
por: Ochiai, Yushi, et al.
Publicado: (2018) -
IFN-β sensitizes TRAIL-induced apoptosis by upregulation of death receptor 5 in malignant glioma cells
por: Yoshimura, Sodai, et al.
Publicado: (2019) -
Efficacy of ribavirin against malignant glioma cell lines
por: OGINO, AKIYOSHI, et al.
Publicado: (2014) -
Antitumor effect of lenalidomide in malignant glioma cell lines
por: Hanashima, Yuya, et al.
Publicado: (2020) -
Characterization of glioma stem-like cells from human glioblastomas
por: YAMAMURO, SHUN, et al.
Publicado: (2015)